Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poszepczynska, E.
Right arrow Articles by Bensussan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poszepczynska, E.
Right arrow Articles by Bensussan, A.
Related Collections
Right arrow Immunobiology
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 96 No. 3 (August 1), 2000: pp. 1056-1063

Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma

Eva Poszepczynska, Martine Bagot, Hamid Echchakir, Denis Martinvalet, Mohamed Ramez, Dominique Charue, Laurence Boumsell, and Armand Bensussan

From Institut National de la Santé et de la Recherche Médicale (INSERM) 448, IM3, Paris XII, Hôpital Henri Mondor, Créteil, France.

CDR3 of the functional rearranged T-cell receptor variable beta  region (TCR-Vbeta ) transcript was sequenced in order to demonstrate for the first time the identity between a long-term cultured T-cell line derived from a cutaneous T-cell lymphoma (CTCL) patient and the malignant T-cell clone present in the blood. The patient's peripheral blood lymphocyte-derived cultured T-cell line had a CD3+Vbeta 22+CD4+CD8alpha alpha +CD25- phenotype. It was named Pno and had been cultured for more than 1 year. Both fresh and long-term-cultured tumor cells proliferated highly in response to interleukin-7 (IL-7), and exogeneous IL-7 prevented Pno lymphocytes from apoptosis and maintained high levels of Bcl-2 expression. This unique malignant cloned lymphocyte line was further used to carry out functional studies. The results indicated that the CD3/TCR structures expressed by the Pno lymphocytes were functional because an immobilized anti-CD3 monoclonal antibody (mAb) or the combination of a soluble anti-CD3 mAb with submitogenic doses of phorbol 12 beta -myristate 13 alpha -acetate induced a proliferative response. Further, the CD2 and CD28 coreceptors were functional because they were able to induce a strong proliferative response upon their specific stimulation. Finally, the Pno T cell line had a Th3-type cytokine profile because it produced high amounts of the immunosuppressor cytokine tumor growth factor-beta 1 (TGF-beta 1). This high production of TGF-beta 1 may inhibit antitumor specific responses in CTCL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
N. Ortonne, D. Huet, C. Gaudez, A. Marie-Cardine, V. Schiavon, M. Bagot, P. Musette, and A. Bensussan
Significance of circulating T-cell clones in Sezary syndrome
Blood, May 15, 2006; 107(10): 4030 - 4038.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Sors, F. Jean-Louis, C. Pellet, L. Laroche, L. Dubertret, G. Courtois, H. Bachelez, and L. Michel
Down-regulating constitutive activation of the NF-{kappa}B canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
Blood, March 15, 2006; 107(6): 2354 - 2363.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Nikolova, P. Musette, M. Bagot, L. Boumsell, and A. Bensussan
Engagement of ILT2/CD85j in Sezary syndrome cells inhibits their CD3/TCR signaling
Blood, July 18, 2002; 100(3): 1019 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Nikolova, A. Marie-Cardine, L. Boumsell, and A. Bensussan
BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression
Int. Immunol., May 1, 2002; 14(5): 445 - 451.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Nielsen, M. H. Nissen, J. Gerwien, M.-B. Zocca, H. M. Rasmussen, K. Nakajima, C. Ropke, C. Geisler, K. Kaltoft, and N. Odum
Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3
Blood, February 1, 2002; 99(3): 973 - 977.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Bagot, A. Moretta, S. Sivori, R. Biassoni, C. Cantoni, C. Bottino, L. Boumsell, and A. Bensussan
CD4+ cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor
Blood, March 1, 2001; 97(5): 1388 - 1391.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020